{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:28:21Z","timestamp":1791253701980,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.cca.2010.06.001","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T08:34:27Z","timestamp":1276331667000},"page":"1632-1636","source":"Crossref","is-referenced-by-count":28,"title":["HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application"],"prefix":"10.1016","volume":"411","author":[{"given":"Mariela","family":"Ivanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Artusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Maria","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2010.06.001_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetric dimethylarginine: the Uber marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2010.06.001_bib2","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/ATVBAHA.107.147595","article-title":"Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure","volume":"27","author":"D\u00fcckelmann","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2010.06.001_bib3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/dc07-0019","article-title":"Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes","volume":"30","author":"Krzyzanowska","year":"2007","journal-title":"Diab Care"},{"key":"10.1016\/j.cca.2010.06.001_bib4","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2010.06.001_bib5","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2010.06.001_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of L-arginine analogue and L-arginine transport mediated by the y+carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.cca.2010.06.001_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cca.2010.06.001_bib8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2010.06.001_bib9","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc09-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"32","author":"American Diabetes Association","year":"2009","journal-title":"Diab Care"},{"key":"10.1016\/j.cca.2010.06.001_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2010.06.001_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ab.2006.03.010","article-title":"Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column","volume":"353","author":"de Jong","year":"2006","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2010.06.001_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.2001.5575","article-title":"Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography","volume":"303","author":"Teerlink","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2010.06.001_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.V891437","article-title":"Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients","volume":"8","author":"Anderstam","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2010.06.001_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1515\/CCLM.2005.197","article-title":"Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance","volume":"43","author":"Teerlink","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2010.06.001_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2010.06.001_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/00365510701429836","article-title":"Health-associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high-performance liquid chromatography","volume":"67","author":"Hov","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cca.2010.06.001_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2006.09.023","article-title":"An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations","volume":"851","author":"Horowitz","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cca.2010.06.001_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2006.07.024","article-title":"HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids","volume":"851","author":"Teerlink","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cca.2010.06.001_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2362.2005.01561.x","article-title":"Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects","volume":"35","author":"Schulze","year":"2005","journal-title":"Eur J Clin Invest."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110003803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110003803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T10:54:48Z","timestamp":1635504888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110003803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":19,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0009898110003803"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2010.06.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}